Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug

March 10, 2025 World Leave a comment 0 Views

Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.

Check Also

Michigan nuclear plant shows challenges US safely restart old reactors

The Palisades nuclear power plant in Covert, Michigan, Feb. 24, 2025. Spencer Kimball | CNBC …

Leave a Reply

Your email address will not be published. Required fields are marked *